SGLT2i pharmacological treatment in type 2 diabetes mellitus control and its underlying obesity. Rev Port Med Geral Fam [Internet]. 30 de Abril de 2024 [citado 9 de Março de 2025];40(2):148-56. Disponível em: https://rpmgf.pt/ojs/index.php/rpmgf/article/view/13647